Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

47.79 +0.61 (+1.29%)

Streaming Delayed Price Updated: 11:32 AM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

42 43 Next >

Vir Soars As Its Addition To SmallCap 600 Helps Wipe Out Recent Covid Volatility ↗

March 30, 2022

Vir Biotechnology remains under pressure despite its looming addition to a new index.

Via Investor's Business Daily

The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict ↗

March 30, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ ↗

March 30, 2022

According to the Centers for Disease Control and Prevention estimates, the omicron BA.2 variant represents approximately 55% of new COVID-19 cases in the U.S., as signs suggest infections are edging...

Via Benzinga

FDA Approves ViiV Healthcare's Cabenuva For Virologically Suppressed Adolescents With HIV ↗

March 29, 2022

Via Benzinga

LifeMine Therapeutics, GSK Ink $70M Drug Discovery, Development Pact ↗

March 23, 2022

Via Benzinga

Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness ↗

March 29, 2022

President Biden's budget proposal calls for $81.7 billion to spend over five years preparing for future pandemics, which would be a significant investment in boosting the country

Via Benzinga

Monday Markets News ↗

March 28, 2022

Japanese Takeda TAK shares failed to thrive after its edema prevention drug was approved.

Via Talk Markets

FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant ↗

March 28, 2022

Via Benzinga

Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs ↗

March 28, 2022

As these Chinese stocks face delisting, some may provide a contrarian play on improving relations between the U.S. and China.

Via InvestorPlace

Drug makers, Scientists Working For Long COVID Treatments: Reuters ↗

March 25, 2022

Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID,

Via Benzinga

How Rivals Merck, Bristol Myers Benefit From Eli Lilly's FDA Snag ↗

March 24, 2022

The Food and Drug Administration on Thursday rejected a lung cancer drug Eli Lilly tested only in China, but LLY stock inched higher.

Via Investor's Business Daily

Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC ↗

March 24, 2022

The COVID-19 pandemic has led to over 6 million fatalities. The scientists are still studying why most children do not suffer badly from coronavirus infection.

Via Benzinga

Ahead Of Moderna's Midstage mRNA Flu Vaccine Readout, Analyst Says Drugmaker Likely To Be First To Market ↗

March 21, 2022

After COVID-19 vaccine-induced strength, Moderna, Inc. (NASDAQ: MRNA) is on the lookout for the next big catalyst to boost its rangebound stock. The Moderna Analyst: BofA...

Via Benzinga

Health Experts Forecast Increase In COVID-19 Cases In US Amid New Omicron Subvariant: CNBC ↗

March 21, 2022

U.S. health experts warn that an emerging, highly contagious COVID-19 omicron variant, BA.2, could soon increase domestic coronavirus cases.

Via Benzinga

WHO Foundation Warns Global Economy To Lose "Trillions Of Dollars" On COVID-19 Vaccine Inequality: CNBC ↗

March 16, 2022

The WHO Foundation CEO, Anil Soni, has told CNBC that the global economy will lose “trillions of dollars” if more COVID-19 vaccines aren&

Via Benzinga

News-Filled Day ↗

March 15, 2022

The price of oil fell to below $100/oz on the prospect of lower demand from the PRC.

Via Talk Markets

Ideaya Biosciences' IDE397 Shows Preliminary Tolerability In Early-Stage Solid Tumor Trial ↗

March 15, 2022

IDEAYA Biosciences Inc (NASDAQ: IDYA) has announced

Via Benzinga

GSK/Vir Biotech's COVID-19 Antibody Associated With Resistance Mutations, New Research Shows ↗

March 11, 2022

According to new research in Australia, some people have developed sotrovimab-resistant mutations following infusions with the GlaxoSmithKline Plc (NYSE: GSK...

Via Benzinga

7 Drug Stocks to Consider After the Viatris Plunge ↗

March 10, 2022

As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market.

Via InvestorPlace

Pharmaceutical Companies Are Reportedly Refocusing On Mysterious Rise In Shingles Infections As COVID Declines ↗

March 07, 2022

Photo Credit: Photo by CDC & Klara Kulikova This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be...

Via Benzinga

36 Stocks To Watch After Biden's First State of The Union Address ↗

March 02, 2022

President Joe Biden hosted his first State of the Union Address Tuesday in front of members of Congress. In the speech, Biden discussed several items that he has already helped...

Via Benzinga

Putin on the brink ↗

February 28, 2022

For the first time in history, Swiss banks have penalized account owners for political actions and joined a SWIFT boycott.

Via Talk Markets

GSK Stops Additional Three Respiratory Virus Vaccine Trials In Pregnant Women ↗

February 28, 2022

GlaxoSmithKline Plc (NYSE: GSK) has halted enrollment and vaccination in three trials of its experimental vaccine against the respiratory syncytial virus (RSV) in...

Via Benzinga

Does the FDA Rollback Of Regeneron And Eli Lilly COVID Treatment EUAs Signal A Need To Look Beyond Monoclonal Antibodies? NanoViricides, Inc. Looks To Meet This Need With A New Approach ↗

February 28, 2022

Photo credit: Marcelo Leal and Kate Hliznitsova on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended...

Via Benzinga

Does CBD Have To Be Water Soluble? One Group Of Scientists Say Yes For Better Absorption ↗

February 25, 2022

Several former scientists and staff from companies like Johnson & Johnson (NYSE:

Via Benzinga

AstraZeneca, GSK's COVID-19 Therapies Lose Efficacy Against Omicron's Subvariants ↗

February 25, 2022

The FDA authorized an increased dose in the case of AstraZeneca Plc's (NASDAQ: AZN) pre-exposure prophylaxis drug Evusheld (tixagevimab and cilgavimab)....

Via Benzinga

Canada Approves First Plant-Based COVID-19 Vaccine ↗

February 25, 2022

As Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline Plc's (NYSE: GSK) COVID-19 vaccine finally heads to regulators, another shot using GSK's pandemic...

Via Benzinga

Red Ink ↗

February 24, 2022

There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph

Via Talk Markets

A Receding tide ↗

February 23, 2022

Sanofi and GlaxoSmithKline have developed a new Covid-19 vaccine which they claim is 100% efficient.

Via Talk Markets

Sanofi-GSK Prepare Regulatory Filings For COVID-19 Vaccine After Booster Data ↗

February 23, 2022

Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (NYSE: GSK) are seeking regulatory approval for their COVID-19 vaccine to be used as a booster, as well as...

Via Benzinga

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

42 43 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Starting at $3.75/week.

Subscribe Today